发明名称 POLYPEPTIDES BINDING TO HUMAN COMPLEMENT C5
摘要 The present invention relates to C5 binding polypeptides, comprising a C5 binding motif, BM, which motif consists of an amino acid sequence selected from i) EX2X3X4A X6X7EID X11LPNL X16X17X18QW X21AFIX23X26LX28D, and ii) an amino acid sequence which has at least 86% identity to the sequence defined in i), wherein the polypeptide binds to C5. The present invention moreover relates to C5 binding polypeptides for use in therapy, such as for use in treatment of a C5 related condition, and to methods of treatments.
申请公布号 US2015011474(A1) 申请公布日期 2015.01.08
申请号 US201314378522 申请日期 2013.02.19
申请人 Swedish Orphan Biovitrum AB 发明人 Berghard Charlotta;Berglund Magnus;Strömberg Patrik;Lindborg Malin;Gunneriusson Elin;Feldwisch Joachim
分类号 A61K38/16;C07K14/195;C07K14/315 主分类号 A61K38/16
代理机构 代理人
主权项 1. A C5 binding polypeptide, comprising a C5 binding motif, BM, which motif consists of an amino acid sequence selected fromi)(SEQ ID NO: 763)EX2X3X4A X6X7EID X11LPNL X16X17X18QW X21AFIX25 X26LX28D,  wherein, independently of each other, X2 is selected from H, Q, S, T and V;X3 is selected from I, L, M and V;X4 is selected from A, D, E, H, K, L, N, Q, R, S, T and Y;X6 is selected from N and W;X7 is selected from A, D, E, H, N, Q, R, S and T;X11 is selected from A, E, G, H, K, L, Q, R, S, T and Y;X16 is selected from N and T;X17 is selected from I, L and V;X18 is selected from A, D, E, H, K, N, Q, R, S and T;X21 is selected from I, L and V;X25 is selected from D, E, G, H, N, S and T;X26 is selected from K and S;X28 is selected from A, D, E, H, N, Q, S, T and Y;and ii) an amino acid sequence which has at least 86% identity to the sequence defined in i), wherein the polypeptide binds to C5.
地址 Stockholm SE